{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:34:26Z","timestamp":1787164466311,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhenjiang Science and Technology Plan\u2014Social Development Project","award":["SH2024064"],"award-info":[{"award-number":["SH2024064"]}]},{"name":"Jiangsu University Affiliated Hospital \u201c5123\u201d talent program excellent discipline leader training fund"},{"DOI":"10.13039\/501100013078","name":"Natural Science Research Project of Guizhou Province","doi-asserted-by":"publisher","award":["HABL202244"],"award-info":[{"award-number":["HABL202244"]}],"id":[{"id":"10.13039\/501100013078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["HAB2024024"],"award-info":[{"award-number":["HAB2024024"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04526-9","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:33:56Z","timestamp":1753882436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis by inhibiting hepatocyte ferroptosis and macrophage polarization via the miR-455-3p\/PLAU axis"],"prefix":"10.1186","volume":"16","author":[{"given":"Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwen","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"3","key":"4526_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4526_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"4526_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin L, et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718\u201335.","journal-title":"J Hepatol"},{"issue":"5","key":"4526_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64(5):830\u201341.","journal-title":"Gut"},{"issue":"12","key":"4526_CR5","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","volume":"14","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, et al. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells. Autophagy. 2018;14(12):2083\u2013103.","journal-title":"Autophagy"},{"issue":"15","key":"4526_CR6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1042\/CS20180177","volume":"132","author":"J Li","year":"2018","unstructured":"Li J, et al. HMGB1-induced autophagy facilitates hepatic stellate cells activation: a new pathway in liver fibrosis. Clin Sci Lond. 2018;132(15):1645\u201367.","journal-title":"Clin Sci Lond"},{"issue":"4","key":"4526_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cmi.2011.53","volume":"9","author":"R Xu","year":"2012","unstructured":"Xu R, Zhang Z, Wang FS. Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol. 2012;9(4):296\u2013301.","journal-title":"Cell Mol Immunol"},{"issue":"14","key":"4526_CR8","doi-asserted-by":"publisher","first-page":"24638","DOI":"10.3390\/ijms25147873","volume":"25","author":"H Akkiz","year":"2024","unstructured":"Akkiz H, Gieseler RK, Canbay A. Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells. Int J Mol Sci. 2024;25(14):24638.","journal-title":"Int J Mol Sci"},{"key":"4526_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2025.02.045","volume":"231","author":"Z Xiong","year":"2025","unstructured":"Xiong Z, et al. Human umbilical cord-derived mesenchymal stem cells attenuate liver fibrosis by inhibiting hepatocyte ferroptosis through mitochondrial transfer. Free Radic Biol Med. 2025;231:163\u201377.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"4526_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2025.102578","volume":"49","author":"C Zhang","year":"2025","unstructured":"Zhang C, et al. Research progress on the regulatory role of different cell death pathways in metabolic-dysfunction-associated steatotic liver disease. Clin Res Hepatol Gastroenterol. 2025;49(6): 102578.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4526_CR11","doi-asserted-by":"publisher","first-page":"1551003","DOI":"10.3389\/fcell.2025.1551003","volume":"13","author":"K Wu","year":"2025","unstructured":"Wu K, et al. Ferritinophagy: multifaceted roles and potential therapeutic strategies in liver diseases. Front Cell Dev Biol. 2025;13:1551003.","journal-title":"Front Cell Dev Biol"},{"key":"4526_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105687","volume":"74","author":"D Ma","year":"2019","unstructured":"Ma D, et al. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol. 2019;74: 105687.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4526_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41420-023-01347-8","volume":"9","author":"KJ Wu","year":"2023","unstructured":"Wu KJ, et al. Regulatory T cells (Tregs) in liver fibrosis. Cell Death Discov. 2023;9(1):53.","journal-title":"Cell Death Discov"},{"issue":"6","key":"4526_CR14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10529-017-2315-4","volume":"39","author":"F Mao","year":"2017","unstructured":"Mao F, et al. Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages. Biotechnol Lett. 2017;39(6):929\u201338.","journal-title":"Biotechnol Lett"},{"issue":"Pt A","key":"4526_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111134","volume":"125","author":"M Yuan","year":"2023","unstructured":"Yuan M, et al. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p\/SLIT3 axis. Int Immunopharmacol. 2023;125(Pt A): 111134.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"4526_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.yexcr.2016.03.015","volume":"343","author":"A Raut","year":"2016","unstructured":"Raut A, Khanna A. Enhanced expression of hepatocyte-specific microRNAs in valproic acid mediated hepatic trans-differentiation of human umbilical cord derived mesenchymal stem cells. Exp Cell Res. 2016;343(2):237\u201347.","journal-title":"Exp Cell Res"},{"issue":"1","key":"4526_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13287-022-03030-8","volume":"13","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, et al. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway. Stem Cell Res Ther. 2022;13(1):354.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4526_CR18","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang X, et al. Micrornas as regulators, biomarkers and therapeutic targets in liver diseases. Gut. 2021;70(4):784\u201395.","journal-title":"Gut"},{"issue":"52","key":"4526_CR19","doi-asserted-by":"publisher","first-page":"37082","DOI":"10.1074\/jbc.M113.517953","volume":"288","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, et al. The autoregulatory feedback loop of microRNA-21\/programmed cell death protein 4\/activation protein-1 (miR-21\/PDCD4\/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem. 2013;288(52):37082\u201393.","journal-title":"J Biol Chem"},{"issue":"2","key":"4526_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jcmm.16119","volume":"25","author":"Z Du","year":"2021","unstructured":"Du Z, et al. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis. J Cell Mol Med. 2021;25(2):701\u201315.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"4526_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13238-012-2036-3","volume":"3","author":"J Hu","year":"2012","unstructured":"Hu J, et al. MiR-122 in hepatic function and liver diseases. Protein Cell. 2012;3(5):364\u201371.","journal-title":"Protein Cell"},{"issue":"1","key":"4526_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1507\/endocrj.EJ24-0317","volume":"72","author":"F Liu","year":"2025","unstructured":"Liu F, et al. Microrna-122 protects against interferon-alpha-induced hepatic inflammatory response via the Janus kinase-signal transducer and activator of transcription pathway. Endocr J. 2025;72(1):53\u201367.","journal-title":"Endocr J"},{"key":"4526_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112934","volume":"141","author":"HA Al Saihati","year":"2024","unstructured":"Al Saihati HA, et al. Exploring the cytoprotective role of mesenchymal stem cell-derived exosomes in chronic liver fibrosis: insights into the Nrf2\/Keap1\/p62 signaling pathway. Int Immunopharmacol. 2024;141: 112934.","journal-title":"Int Immunopharmacol"},{"key":"4526_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.omtn.2019.05.001","volume":"16","author":"S Wei","year":"2019","unstructured":"Wei S, et al. Mir-455-3p alleviates hepatic stellate cell activation and liver fibrosis by suppressing HSF1 expression. Mol Ther Nucleic Acids. 2019;16:758\u201369.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4526_CR25","doi-asserted-by":"publisher","first-page":"6685605","DOI":"10.1155\/2021\/6685605","volume":"2021","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, et al. Human umbilical cord mesenchymal stem cells ameliorate hepatic stellate cell activation and liver fibrosis by upregulating MicroRNA-455-3p through suppression of p21-Activated Kinase-2. Biomed Res Int. 2021;2021:6685605.","journal-title":"Biomed Res Int"},{"issue":"1","key":"4526_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13287-020-1550-0","volume":"11","author":"M Shao","year":"2020","unstructured":"Shao M, et al. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. Stem Cell Res Ther. 2020;11(1):37.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4526_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113510","volume":"425","author":"C Ma","year":"2023","unstructured":"Ma C, et al. Downregulation of miR-455-3p in decidual cells promotes macrophage polarization and suppresses trophoblasts invasion. Exp Cell Res. 2023;425(2): 113510.","journal-title":"Exp Cell Res"},{"issue":"1","key":"4526_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12935-024-03422-1","volume":"24","author":"S Dai","year":"2024","unstructured":"Dai S, et al. Mir-455\/GREM1 axis promotes colorectal cancer progression and liver metastasis by affecting PI3K\/AKT pathway and inducing M2 macrophage polarization. Cancer Cell Int. 2024;24(1):235.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4526_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2249.2008.03606.x","volume":"152","author":"AA Higazi","year":"2008","unstructured":"Higazi AA, et al. Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis. Clin Exp Immunol. 2008;152(1):163\u201373.","journal-title":"Clin Exp Immunol"},{"key":"4526_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-230X-6-40","volume":"6","author":"K Shanmukhappa","year":"2006","unstructured":"Shanmukhappa K, et al. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor. BMC Gastroenterol. 2006;6:40.","journal-title":"BMC Gastroenterol"},{"key":"4526_CR31","doi-asserted-by":"publisher","first-page":"1086368","DOI":"10.3389\/fgene.2023.1086368","volume":"14","author":"M Li","year":"2023","unstructured":"Li M, et al. Development of alternative herbals remedy for gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis. Front Genet. 2023;14:1086368.","journal-title":"Front Genet"},{"issue":"8","key":"4526_CR32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/cbin.12025","volume":"47","author":"MD Hu","year":"2023","unstructured":"Hu MD, Jia LH, Wang ML. PLAU contributes to the development of cholangiocarcinoma via activating NF-kappaB signaling pathway. Cell Biol Int. 2023;47(8):1381\u201391.","journal-title":"Cell Biol Int"},{"issue":"3","key":"4526_CR33","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.21037\/jgo-23-311","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu J, et al. Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma. J Gastrointest Oncol. 2023;14(3):1434\u201350.","journal-title":"J Gastrointest Oncol"},{"issue":"7","key":"4526_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41418-017-0006-2","volume":"25","author":"G Wang","year":"2018","unstructured":"Wang G, et al. Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ. 2018;25(7):1209\u201323.","journal-title":"Cell Death Differ"},{"key":"4526_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107183","volume":"163","author":"A Mijit","year":"2023","unstructured":"Mijit A, et al. Mapping synthetic binding proteins epitopes on diverse protein targets by protein structure prediction and protein-protein docking. Comput Biol Med. 2023;163: 107183.","journal-title":"Comput Biol Med"},{"issue":"5","key":"4526_CR36","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan Y, et al. The HDOCK server for integrated protein-protein docking. Nat Protoc. 2020;15(5):1829\u201352.","journal-title":"Nat Protoc"},{"issue":"2","key":"4526_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jss.2006.09.018","volume":"141","author":"S Dinant","year":"2007","unstructured":"Dinant S, et al. IL-10 attenuates hepatic I\/R injury and promotes hepatocyte proliferation. J Surg Res. 2007;141(2):176\u201382.","journal-title":"J Surg Res"},{"issue":"2","key":"4526_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209\u201318.","journal-title":"J Clin Invest"},{"issue":"2","key":"4526_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1535370219898141","volume":"245","author":"D Dhar","year":"2020","unstructured":"Dhar D, et al. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood). 2020;245(2):96\u2013108.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"4526_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1517\/14728222.8.5.423","volume":"8","author":"JA Fallowfield","year":"2004","unstructured":"Fallowfield JA, Iredale JP. Targeted treatments for cirrhosis. Expert Opin Ther Targets. 2004;8(5):423\u201335.","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"4526_CR41","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s12015-022-10335-x","volume":"18","author":"X Mi","year":"2022","unstructured":"Mi X, et al. HGF secreted by mesenchymal stromal cells promotes primordial follicle activation by increasing the activity of the PI3K-AKT signaling pathway. Stem Cell Rev Rep. 2022;18(5):1834\u201350.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"4526_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13287-022-02728-z","volume":"13","author":"Y He","year":"2022","unstructured":"He Y, et al. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1\/Stat3 signaling. Stem Cell Res Ther. 2022;13(1):65.","journal-title":"Stem Cell Res Ther"},{"issue":"22","key":"4526_CR43","first-page":"7621","volume":"22","author":"J Xu","year":"2018","unstructured":"Xu J, et al. HGF alleviates renal interstitial fibrosis via inhibiting the TGF-beta1\/SMAD pathway. Eur Rev Med Pharmacol Sci. 2018;22(22):7621\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"21","key":"4526_CR44","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1089\/scd.2021.0136","volume":"30","author":"F Yin","year":"2021","unstructured":"Yin F, et al. Effect of hepatocyte growth factor-transfected human umbilical cord mesenchymal stem cells on hepatic stellate cells by regulating transforming growth factor-beta1\/Smads signaling pathway. Stem Cells Dev. 2021;30(21):1070\u201381.","journal-title":"Stem Cells Dev"},{"key":"4526_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.808855","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, et al. HGF\/c-Met: a key promoter in liver regeneration. Front Pharmacol. 2022;13: 808855.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4526_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10529-025-03579-3","volume":"47","author":"MS Choi","year":"2025","unstructured":"Choi MS, et al. Anti-liver fibrotic effects of small extracellular vesicle microRNAs from human umbilical cord-derived mesenchymal stem cells and their differentiated hepatocyte-like cells. Biotechnol Lett. 2025;47(2):38.","journal-title":"Biotechnol Lett"},{"issue":"5\u20136","key":"4526_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/10799893.2019.1585452","volume":"38","author":"XJ Hao","year":"2018","unstructured":"Hao XJ, et al. Mir-21 promotes proliferation and inhibits apoptosis of hepatic stellate cells through targeting PTEN\/PI3K\/AKT pathway. J Recept Signal Transduct Res. 2018;38(5\u20136):455\u201361.","journal-title":"J Recept Signal Transduct Res"},{"issue":"2","key":"4526_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/1566523214666141224095610","volume":"15","author":"S Thakral","year":"2015","unstructured":"Thakral S, Ghoshal K. Mir-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr Gene Ther. 2015;15(2):142\u201350.","journal-title":"Curr Gene Ther"},{"issue":"1","key":"4526_CR49","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1186\/s12967-024-05901-5","volume":"22","author":"S Dai","year":"2024","unstructured":"Dai S, et al. MiR-122\/NEGR1 axis contributes colorectal cancer liver metastasis by PI3K\/AKT pathway and macrophage modulation. J Transl Med. 2024;22(1):1060.","journal-title":"J Transl Med"},{"issue":"1","key":"4526_CR50","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12951-025-03291-4","volume":"23","author":"Z Wang","year":"2025","unstructured":"Wang Z, et al. Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1\/GPX4-mediated ferroptosis in hepatic stellate cells. J Nanobiotechnology. 2025;23(1):222.","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"4526_CR51","first-page":"724","volume":"49","author":"SH Abd-Allah","year":"2024","unstructured":"Abd-Allah SH, et al. Mesenchymal stem cells and their derived exosomes mitigated hepatic cirrhosis in rats by altering the expression of miR-23b and miR-221. Iran J Med Sci. 2024;49(11):724\u201340.","journal-title":"Iran J Med Sci"},{"key":"4526_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137235","author":"L He","year":"2024","unstructured":"He L, et al. MiR-9-5p and miR-221-3p promote human mesenchymal stem cells to alleviate carbon tetrachloride-induced liver injury by enhancing human mesenchymal stem cell engraftment and inhibiting hepatic stellate cell activation. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25137235.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4526_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13287-025-04197-6","volume":"16","author":"W Jiang","year":"2025","unstructured":"Jiang W, et al. Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p\/STING axis. Stem Cell Res Ther. 2025;16(1):74.","journal-title":"Stem Cell Res Ther"},{"key":"4526_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.946832","volume":"13","author":"JH Wen","year":"2022","unstructured":"Wen JH, et al. Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis. Front Immunol. 2022;13: 946832.","journal-title":"Front Immunol"},{"issue":"21","key":"4526_CR55","doi-asserted-by":"publisher","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","volume":"30","author":"D Tang","year":"2020","unstructured":"Tang D, Kroemer G. Ferroptosis. Curr Biol. 2020;30(21):R1292\u20137.","journal-title":"Curr Biol"},{"key":"4526_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04115-w","author":"BI Saeed","year":"2025","unstructured":"Saeed BI, et al. Ferroptosis as a key player in the pathogenesis and intervention therapy in liver injury: focusing on drug-induced hepatotoxicity. Naunyn Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-04115-w.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"4526_CR57","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1080\/01480545.2023.2295230","volume":"47","author":"L Zeng","year":"2024","unstructured":"Zeng L, et al. Ferroptosis: action and mechanism of chemical\/drug-induced liver injury. Drug Chem Toxicol. 2024;47(6):1300\u201311.","journal-title":"Drug Chem Toxicol"},{"issue":"9","key":"4526_CR58","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.bbamcr.2012.03.004","volume":"1823","author":"DM Ward","year":"2012","unstructured":"Ward DM, Kaplan J. Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta. 2012;1823(9):1426\u201333.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"4526_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4526_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6(1):49.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4526_CR61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11033-025-10443-0","volume":"52","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Molecular mechanisms of alcohol-associated liver disease-ferroptosis and autophagy crosstalk. Mol Biol Rep. 2025;52(1):361.","journal-title":"Mol Biol Rep"},{"issue":"5","key":"4526_CR62","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.7150\/thno.106597","volume":"15","author":"M Yan","year":"2025","unstructured":"Yan M, Cui Y, Xiang Q. Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions. Theranostics. 2025;15(5):1715\u201340.","journal-title":"Theranostics"},{"key":"4526_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1462145","volume":"12","author":"C Li","year":"2025","unstructured":"Li C, et al. Ferroptosis in NAFLD: insights and the therapeutic potential of exercise. Front Med (Lausanne). 2025;12: 1462145.","journal-title":"Front Med (Lausanne)"},{"key":"4526_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174351","volume":"908","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, et al. Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4. Eur J Pharmacol. 2021;908: 174351.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"4526_CR65","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, et al. GPX4 in cell death, autophagy, and disease. Autophagy. 2023;19(10):2621\u201338.","journal-title":"Autophagy"},{"issue":"1","key":"4526_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"29","author":"M Maiorino","year":"2018","unstructured":"Maiorino M, Conrad M, Ursini F. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal. 2018;29(1):61\u201374.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"4526_CR67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s13577-022-00820-3","volume":"36","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination. Hum Cell. 2023;36(1):209\u201322.","journal-title":"Hum Cell"},{"key":"4526_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1060957","volume":"13","author":"SMZ Hosen","year":"2022","unstructured":"Hosen SMZ, et al. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: key role of the urokinase plasminogen activator (PLAU). Front Immunol. 2022;13: 1060957.","journal-title":"Front Immunol"},{"issue":"1","key":"4526_CR69","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1186\/s12885-019-6397-3","volume":"19","author":"MC Tsai","year":"2019","unstructured":"Tsai MC, et al. Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection. BMC Cancer. 2019;19(1):1169.","journal-title":"BMC Cancer"},{"issue":"1","key":"4526_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111612","volume":"28","author":"L Liu","year":"2025","unstructured":"Liu L, et al. Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer. iScience. 2025;28(1): 111612.","journal-title":"iScience"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04526-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04526-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04526-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:05:40Z","timestamp":1757318740000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04526-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4526"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04526-9","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent and approval were obtained from all the patients and the Ethics Committee of the Affiliated Hospital of Jiangsu University (Study on improvement of liver fibrosis by mesenchymal stem cells, KY2022K0103, Date: 2022-01-03). All the animal studies were performed following the Guidelines for the Care and Use of Laboratory Animals and were approved by the Ethics Committee of Jiangsu University (The role and application of mesenchymal stem cells in regulating ferroptosis in hepatic fibrosis, UJS-IACUC-AP-2024073031, Date: 2024-07-30).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"412"}}